In the spleen tissues, we found significantly higher percentages of CD4+ and CD8+ T cells in mice treated with combination treatment compared with those that received monotherapy or untreated controls, while tumor-bearing mice had decreased CD4+ T cells (Figures 3A, S2A, B, p< 0.05). The gene discussed is CD8A; the disease is neoplasm.